查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1529730

成体干细胞市场规模、份额、趋势分析报告：按类型、按产品/服务、按适应症、按应用、按最终用途、细分市场预测，2024-2030 年

Adult Stem Cells Market Size, Share & Trend Analysis Report By Type (Autologous Adult Stem Cells, Allogeneic Adult Stem Cells), By Product & Services (Product, Services), By Indication, By Application, By End Use, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

成体干细胞市场规模及趋势

2023 年，全球成体干细胞市场规模为 123.5 亿美元，预计在几个关键因素的推动下，2024 年至 2030 年复合年增长率为 11.2%。这些细胞存在于各种组织和器官中，在再生医学和治疗中具有巨大的应用潜力。在生物技术和分子生物学进步的推动下，成体干细胞疗法的研究与开发 (R&D) 正在蓬勃发展。

科学家正在探索成体干细胞的新来源，优化培养技术，并改进分化成特殊细胞类型的方法。例如，波士顿儿童医院在成人干细胞研究方面取得了重要的里程碑，包括从正常肺部和受肺癌影响的肺部分离出肺干细胞。这些创新为治疗从心血管疾病到神经系统疾病等多种疾病和损伤开闢了潜在的应用前景。

市场最重要的驱动力之一是研发投资的增加。製药公司、生技公司和学术机构正在投入大量资源来探索成人干细胞在各种医疗应用中的治疗潜力。例如，印度生物技术部 (DBT) 正在积极支持 2019 年至 2022 年干细胞研究许多领域的倡议。这些倡议包括基础生物学见解、转化研究计划以及用于电力和临床应用的基因转化技术。在此期间，DBT为这些计划贡献了880万美元。这些投资将支持临床前研究、临床试验和可扩展製造流程的开发。

CRISPR-Cas9 基因编辑和诱导性多功能干细胞(iPSC) 等先进技术正在提高研究人员有效操纵和利用干细胞的能力。随着研究和开发工作取得可喜的成果和法律规范的发展，市场准备扩大并提供创新的解决方案来治疗复杂的疾病并改善全球患者的治疗结果。

此外，慢性病的增加是市场成长的主要动力。由于人口老化和生活方式因素，糖尿病、心血管疾病和神经退化性疾病等疾病呈上升趋势。根据美国疾病管制与预防中心 (CDC) 2024 年 2 月发布的报告，美国约有 1.29 亿人患有至少一种严重慢性病。成体干细胞是一种潜在的治疗方法，可以解决这些疾病的根本原因，提供传统治疗方法无法满足的可再生解决方案。随着医疗保健系统寻求更有效和个人化的方法来管理慢性病，对成体干细胞疗法的需求预计将增长，从而推动临床实践的研发和采用。

此外，世界各地的监管机构也制定了指导方针，以确保成体干细胞治疗的安全性、有效性和道德使用。简化核准流程并清除监管路径将促进商业化和市场扩张的投资，使患者更容易获得先进的治疗方法。

全球成体干细胞市场报告细分

该报告预测了2018年至2030年国家层级的收益成长，并对每个子区隔的最新行业趋势和商机进行了分析。为了本研究的目的，Grand View Research 根据类型、产品和服务、适应症、应用、最终用途和地区对全球成体干细胞市场报告进行了细分。

  • 类型展望（销量，2018-2030）。
  • 自体成体干细胞。
  • 同种异体成体干细胞。
  • 产品与服务展望（销售额，2018-2030 年）。
  • 产品。

套件、培养基和试剂

细胞和细胞株

造血系统

间质

神经系统

上皮/皮肤

其他的

服务

  • 指示展望（销售，2018-2030）。
  • 骨/软骨修復。
  • 心血管疾病。
  • 发炎和免疫疾病。
  • 肝臟疾病。
  • 癌症。
  • 移植物抗宿主疾病。
  • 其他的。
  • 应用前景（销量，2018-2030）。
  • 治疗药物。
  • 疾病建模。
  • 药物开发和发现。
  • 毒理学研究。
  • 生物样本库。
  • 组织工程
  • 其他的
  • 最终用途展望（销售额，2018-2030 年）。
  • 生物製药公司。
  • 研究机构。
  • 医院和诊所。
  • 地区展望（销售额，2018-2030 年）。
  • 北美。

美国

加拿大

墨西哥

  • 欧洲

英国

德国

法国

义大利

西班牙

挪威

丹麦

瑞典

  • 亚太地区

日本

中国

印度

澳洲

韩国

泰国

  • 拉丁美洲

巴西

阿根廷

  • 中东和非洲

南非

沙乌地阿拉伯

阿拉伯聯合大公国

科威特

目录

第一章调查方法与范围

第 2 章执行摘要

第三章成体干细胞市场变数、趋势与范围

  • 市场体系展望
  • 市场动态
  • 成体干细胞市场分析工具

第四章成体干细胞市场：类型估计与趋势分析

  • 细分仪表板
  • 成体干细胞市场：类型变异分析
  • 按类型分類的成体干细胞市场前景
  • 2018-2030年市场规模、预测及趋势分析
  • 自体成体干细胞
  • 同种异体成体干细胞

第五章成体干细胞市场：产品和服务的估计和趋势分析

  • 细分仪表板
  • 成体干细胞市场：产品与服务的波动分析
  • 成体干细胞市场：依产品/服务分類的前景
  • 2018-2030年市场规模、预测及趋势分析
  • 产品

5.5.3.2.1.2018-2030年血液学市场收益估计与预测

5.5.3.3.1. 2018-2030 年间质市场收益估计与预测

5.5.3.4.1. 2018-2030 年神经市场收益估计与预测

5.5.3.5.1. 2018-2030 年上皮/皮肤市场收益估计与预测

5.5.3.6.1.2018-2030年其他市场收益估计及预测

  • 服务
    • 2018-2030年服务市场收益估算与预测

第六章 成体干细胞市场：适应症估计与趋势分析

  • 细分仪表板
  • 成体干细胞市场：适应症变异分析
  • 成体干细胞市场前景（按适应症）
  • 2018-2030年市场规模、预测及趋势分析
  • 骨头和软骨修復
  • 心血管疾病
  • 发炎和免疫疾病
  • 肝臟疾病
  • 癌症
  • 移植物抗宿主疾病
  • 其他的

第七章 成体干细胞市场：应用预估及趋势分析

  • 细分仪表板
  • 成体干细胞市场：应用变化分析
  • 成体干细胞市场 - 依应用分類的前景
  • 2018-2030年市场规模、预测及趋势分析
  • 治疗药物
  • 疾病模型
  • 药物开发和发现
  • 毒理学研究
  • 生物银行
  • 组织工程
  • 其他的

第八章成体干细胞市场：最终用途估计与趋势分析

  • 细分仪表板
  • 成体干细胞市场：最终用途变异分析
  • 以最终用途分類的成体干细胞市场前景
  • 2018-2030年市场规模、预测及趋势分析
  • 生物製药公司
  • 研究所
  • 医院/诊所

第九章成体干细胞市场：区域估计与趋势分析

  • 区域仪表板
  • 成体干细胞市场按地区波动分析
  • 成体干细胞市场：按类型、产品、服务和最终用途分類的区域估计和趋势分析
  • 2018-2030年市场规模、预测及趋势分析
  • 北美洲
    • 2018-2030年北美市场估计与预测
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 2018年至2030年欧洲市场估计与预测
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 2018-2030 年亚太市场估计与预测
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 2018-2030 年拉丁美洲市场估计与预测
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 2018年至2030年中东和非洲市场估计和预测
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第10章竞争格局

  • 市场参与企业分类
  • 2023年主要企业市场分析
  • 主要企业简介
    • Thermo Fisher Scientific, Inc
    • STEMCELL Technologies
    • Osiris Therapeutics
    • ZenBio, Inc.
    • Stempeutics Research
    • Fate Therapeutics, Inc.
    • BrainStorm Cell Therapeutics Inc.
    • Celgene Corporation
    • Stemedica Cell Technologies, Inc.
    • Vericel Corporation
Product Code: GVR-4-68040-338-3

Adult Stem Cells Market Size & Trends

The global adult stem cells market size was valued at USD 12.35 billion in 2023 and is projected to grow at a CAGR of 11.2% from 2024 to 2030, driven by several key factors. These cells, found in various tissues and organs, hold immense potential for regenerative medicine and therapeutic applications. As research continues to uncover their capabilities, the market is poised for significant expansion in the coming years.Research and development (R&D) efforts in adult stem cell therapies have intensified, propelled by advances in biotechnology and molecular biology.

Scientists are exploring new sources of adult stem cells, optimizing culture techniques, and refining methods for differentiation into specialized cell types. For instance, Boston Children's Hospital has achieved significant milestones in adult stem cell research, including the isolation of lung stem cells from both normal lungs and those affected by lung cancer. These innovations are expanding the scope of potential applications in treating a wide range of diseases and injuries, from cardiovascular disorders to neurological conditions.

One of the most important drivers of the market is the increasing investment in research and development. Pharmaceutical companies, biotechnology firms, and academic institutions are allocating significant resources to explore the therapeutic potential of adult stem cells across various medical applications. For instance, the Department of Biotechnology (DBT) in India is actively supporting initiatives in many areas of stem cell research from 2019 to 2022. These initiatives include fundamental biological insights, translational research projects, and genetics conversion technologies for power and clinical applications. During this period, DBT committed USD 8.80 million to these projects. These investments support preclinical studies, clinical trials, and the development of scalable manufacturing processes.

Advanced technologies such as CRISPR-Cas9 gene editing and induced pluripotent stem cells (iPSCs) are enhancing researchers' ability to manipulate and utilize stem cells effectively. As R&D efforts yield promising results and regulatory frameworks evolve, the market is poised to expand, offering innovative solutions for treating complex diseases and improving patient outcomes globally.

In addition, the increasing prevalence of chronic diseases represents a significant driver of market growth. Conditions such as diabetes, cardiovascular diseases, and neurodegenerative disorders are rising due to aging populations and lifestyle factors. As per the February 2024 report released by the CDC, roughly 129 million individuals in the U.S. are impacted by at least one significant chronic illness. Adult stem cells offer potential therapies that can address the underlying causes of these diseases, providing regenerative solutions that traditional treatments often cannot match. As healthcare systems seek more effective and personalized approaches to managing chronic conditions, the demand for adult stem cell therapies is expected to grow, fueling further research, development, and adoption in clinical settings.

Furthermore, regulatory agencies worldwide are establishing guidelines to ensure the safety, efficacy, and ethical use of adult stem cell therapies. Streamlined approval processes and clearer regulatory pathways encourage investment in commercialization and market expansion, facilitating patient access to advanced treatment options.

Global Adult Stem Cells Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis on the latest industry trends and opportunities in each of the sub-segments from 2018 to 2030. For the purpose of this study, Grand View Research has segmented the global adult stem cells market report based on type, product & services, indication, application, end use, and region.

  • Type Outlook (Revenue, USD Billion, 2018 - 2030)
  • Autologous Adult Stem Cells
  • Allogeneic Adult Stem Cells
  • Product & Services Outlook (Revenue, USD Billion, 2018 - 2030)
  • Product

Kits, Media, & Reagents

Cells & cell lines

Hematopoietic

Mesenchymal

Neural

Epithelial/Skin

Others

Services

  • Indication Outlook (Revenue, USD Billion, 2018 - 2030)
  • Bone and Cartilage Repair
  • Cardiovascular Diseases
  • Inflammatory and Immunological Diseases
  • Liver diseases
  • Cancer
  • GvHD
  • Others
  • Application Outlook (Revenue, USD Billion, 2018 - 2030)
  • Therapeutics
  • Disease Modeling
  • Drug Development & Discovery
  • Toxicology Studies
  • Biobanking
  • Tissue Engineering
  • Others
  • End Use Outlook (Revenue, USD Billion, 2018 - 2030)
  • Biopharmaceutical Companies
  • Research Institutes
  • Hospitals & Clinics
  • Regional Outlook (Revenue, USD Billion, 2018 - 2030)
  • North America

U.S.

Canada

Mexico

  • Europe

UK

Germany

France

Italy

Spain

Norway

Denmark

Sweden

  • Asia Pacific

Japan

China

India

Australia

South Korea

Thailand

  • Latin America

Brazil

Argentina

  • Middle East & Africa

South Africa

Saudi Arabia

UAE

Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Product & Services
    • 1.2.3. Indication
    • 1.2.4. Application
    • 1.2.5. End Use
    • 1.2.6. Regional Scope
    • 1.2.7. Estimates and forecasts timeline
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Total Market: CAGR Calculation
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights

Chapter 3. Adult Stem Cells Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Adult stem cells market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Adult Stem Cells Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Adult stem cells market: Type Movement Analysis
  • 4.3. Adult stem cells market by Type Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5. Autologous Adult Stem Cells
    • 4.5.1. Autologous Adult Stem Cells Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Allogeneic Adult Stem Cells
    • 4.6.1. Allogeneic Adult Stem Cells Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Adult Stem Cells Market: Product & Services Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Adult stem cells market: Product & Services Movement Analysis
  • 5.3. Adult stem cells market by Product & Services Outlook (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5. Product
    • 5.5.1. Product Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.2. Kits, Media, & Reagents
      • 5.5.2.1. Kits, Media, & Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.3. Cells & Cell Lines
      • 5.5.3.1. Cells & Cell Lines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 5.5.3.2. Hematopoietic

5.5.3.2.1. Hematopoietic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

      • 5.5.3.3. Mesenchymal

5.5.3.3.1. Mesenchymal Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

      • 5.5.3.4. Neural

5.5.3.4.1. Neural Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

      • 5.5.3.5. Epithelial/Skin

5.5.3.5.1. Epithelial/Skin Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

      • 5.5.3.6. Others

5.5.3.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

  • 5.6. Services
    • 5.6.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Adult Stem Cells Market: Indication Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Adult stem cells market: Indication Movement Analysis
  • 6.3. Adult stem cells market by Indication Outlook (USD Million)
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.5. Bone and Cartilage Repair
    • 6.5.1. Bone and Cartilage Repair Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Cardiovascular Diseases
    • 6.6.1. Cardiovascular Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Inflammatory and Immunological Diseases
    • 6.7.1. Inflammatory and Immunological Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8. Liver Diseases
    • 6.8.1. Liver Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.9. Cancer
    • 6.9.1. Cancer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.10. GvHD
    • 6.10.1. GvHD Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.11. Others
    • 6.11.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Adult Stem Cells Market: Application Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Adult stem cells market: Application Movement Analysis
  • 7.3. Adult stem cells market by Application Outlook (USD Million)
  • 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 7.5. Therapeutics
    • 7.5.1. Therapeutics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Disease Modeling
    • 7.6.1. Disease Modeling Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Drug Development & Discovery
    • 7.7.1. Drug Development & Discovery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8. Toxicology Studies
    • 7.8.1. Toxicology Studies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.9. Biobanking
    • 7.9.1. Biobanking Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.10. Tissue Engineering
    • 7.10.1. Tissue Engineering Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.11. Others
    • 7.11.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Adult Stem Cells Market: End Use Estimates & Trend Analysis

  • 8.1. Segment Dashboard
  • 8.2. Adult stem cells market: End Use Movement Analysis
  • 8.3. Adult stem cells market by End Use Outlook (USD Million)
  • 8.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 8.5. Biopharmaceutical Companies
    • 8.5.1. Biopharmaceutical Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Research Institutes
    • 8.6.1. Research Institutes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7. Hospitals & Clinics
    • 8.7.1. Hospitals & Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Adult Stem Cells Market: Regional Estimates & Trend Analysis

  • 9.1. Regional Dashboard
  • 9.2. Regional Adult stem cells market movement analysis
  • 9.3. Adult stem cells market: Regional Estimates & Trend Analysis by Type, Product & Services & End-use
  • 9.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 9.5. North America
    • 9.5.1. North America market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.2. U.S.
      • 9.5.2.1. Key country dynamics
      • 9.5.2.2. Competitive scenario
      • 9.5.2.3. Regulatory framework
      • 9.5.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.3. Canada
      • 9.5.3.1. Key country dynamics
      • 9.5.3.2. Competitive scenario
      • 9.5.3.3. Regulatory framework
      • 9.5.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.4. Mexico
      • 9.5.4.1. Key country dynamics
      • 9.5.4.2. Competitive scenario
      • 9.5.4.3. Regulatory framework
      • 9.5.4.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6. Europe
    • 9.6.1. Europe market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.2. UK
      • 9.6.2.1. Key country dynamics
      • 9.6.2.2. Competitive scenario
      • 9.6.2.3. Regulatory framework
      • 9.6.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.3. Germany
      • 9.6.3.1. Key country dynamics
      • 9.6.3.2. Competitive scenario
      • 9.6.3.3. Regulatory framework
      • 9.6.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.4. France
      • 9.6.4.1. Key country dynamics
      • 9.6.4.2. Competitive scenario
      • 9.6.4.3. Regulatory framework
      • 9.6.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.5. Italy
      • 9.6.5.1. Key country dynamics
      • 9.6.5.2. Competitive scenario
      • 9.6.5.3. Regulatory framework
      • 9.6.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.6. Spain
      • 9.6.6.1. Key country dynamics
      • 9.6.6.2. Competitive scenario
      • 9.6.6.3. Regulatory framework
      • 9.6.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.7. Denmark
      • 9.6.7.1. Key country dynamics
      • 9.6.7.2. Competitive scenario
      • 9.6.7.3. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.8. Sweden
      • 9.6.8.1. Key country dynamics
      • 9.6.8.2. Competitive scenario
      • 9.6.8.3. Regulatory framework
      • 9.6.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.9. Norway
      • 9.6.9.1. Key country dynamics
      • 9.6.9.2. Competitive scenario
      • 9.6.9.3. Regulatory framework
      • 9.6.9.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.7. Asia Pacific
    • 9.7.1. Asia Pacific market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.7.2. Japan
      • 9.7.2.1. Key country dynamics
      • 9.7.2.2. Competitive scenario
      • 9.7.2.3. Regulatory framework
      • 9.7.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.7.3. China
      • 9.7.3.1. Key country dynamics
      • 9.7.3.2. Competitive scenario
      • 9.7.3.3. Regulatory framework
      • 9.7.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.7.4. India
      • 9.7.4.1. Key country dynamics
      • 9.7.4.2. Competitive scenario
      • 9.7.4.3. Regulatory framework
      • 9.7.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.7.5. Australia
      • 9.7.5.1. Key country dynamics
      • 9.7.5.2. Competitive scenario
      • 9.7.5.3. Regulatory framework
      • 9.7.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.7.6. South Korea
      • 9.7.6.1. Key country dynamics
      • 9.7.6.2. Competitive scenario
      • 9.7.6.3. Regulatory framework
      • 9.7.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.7.7. Thailand
      • 9.7.7.1. Key country dynamics
      • 9.7.7.2. Competitive scenario
      • 9.7.7.3. Regulatory framework
      • 9.7.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.8. Latin America
    • 9.8.1. Latin America market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.8.2. Brazil
      • 9.8.2.1. Key country dynamics
      • 9.8.2.2. Competitive scenario
      • 9.8.2.3. Regulatory framework
      • 9.8.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.8.3. Argentina
      • 9.8.3.1. Key country dynamics
      • 9.8.3.2. Competitive scenario
      • 9.8.3.3. Regulatory framework
      • 9.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.9. MEA
    • 9.9.1. MEA market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.9.2. South Africa
      • 9.9.2.1. Key country dynamics
      • 9.9.2.2. Competitive scenario
      • 9.9.2.3. Regulatory framework
      • 9.9.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.9.3. Saudi Arabia
      • 9.9.3.1. Key country dynamics
      • 9.9.3.2. Competitive scenario
      • 9.9.3.3. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.9.4. UAE
      • 9.9.4.1. Key country dynamics
      • 9.9.4.2. Competitive scenario
      • 9.9.4.3. Regulatory framework
      • 9.9.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.9.5. Kuwait
      • 9.9.5.1. Key country dynamics
      • 9.9.5.2. Competitive scenario
      • 9.9.5.3. Regulatory framework
      • 9.9.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Market Participant Categorization
  • 10.2. Key Company Market Position Analysis, 2023
  • 10.3. Key Company Profiles
    • 10.3.1. Thermo Fisher Scientific, Inc
      • 10.3.1.1. Company overview
      • 10.3.1.2. Financial performance
      • 10.3.1.3. Product benchmarking
      • 10.3.1.4. Strategic initiatives
    • 10.3.2. STEMCELL Technologies
      • 10.3.2.1. Company overview
      • 10.3.2.2. Financial performance
      • 10.3.2.3. Product benchmarking
      • 10.3.2.4. Strategic initiatives
    • 10.3.3. Osiris Therapeutics
      • 10.3.3.1. Company overview
      • 10.3.3.2. Financial performance
      • 10.3.3.3. Product benchmarking
      • 10.3.3.4. Strategic initiatives
    • 10.3.4. ZenBio, Inc.
      • 10.3.4.1. Company overview
      • 10.3.4.2. Financial performance
      • 10.3.4.3. Product benchmarking
      • 10.3.4.4. Strategic initiatives
    • 10.3.5. Stempeutics Research
      • 10.3.5.1. Company overview
      • 10.3.5.2. Financial performance
      • 10.3.5.3. Product benchmarking
      • 10.3.5.4. Strategic initiatives
    • 10.3.6. Fate Therapeutics, Inc.
      • 10.3.6.1. Company overview
      • 10.3.6.2. Financial performance
      • 10.3.6.3. Product benchmarking
      • 10.3.6.4. Strategic initiatives
    • 10.3.7. BrainStorm Cell Therapeutics Inc.
      • 10.3.7.1. Company overview
      • 10.3.7.2. Financial performance
      • 10.3.7.3. Product benchmarking
      • 10.3.7.4. Strategic initiatives
    • 10.3.8. Celgene Corporation
      • 10.3.8.1. Company overview
      • 10.3.8.2. Financial performance
      • 10.3.8.3. Product benchmarking
      • 10.3.8.4. Strategic initiatives
    • 10.3.9. Stemedica Cell Technologies, Inc.
      • 10.3.9.1. Company overview
      • 10.3.9.2. Financial performance
      • 10.3.9.3. Product benchmarking
      • 10.3.9.4. Strategic initiatives
    • 10.3.10. Vericel Corporation
      • 10.3.10.1. Company overview
      • 10.3.10.2. Financial performance
      • 10.3.10.3. Product benchmarking
      • 10.3.10.4. Strategic initiatives

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. Global adult stem cells market, by type, 2018 - 2030 (USD Million)
  • Table 4. Global adult stem cells market, by product & services, 2018 - 2030 (USD Million)
  • Table 5. Global adult stem cells market, by indication, 2018 - 2030 (USD Million)
  • Table 6. Global adult stem cells market, by application, 2018 - 2030 (USD Million)
  • Table 7. Global adult stem cells market, by end use, 2018 - 2030 (USD Million)
  • Table 8. North America adult stem cells market, by region, 2018 - 2030 (USD Million)
  • Table 9. North America adult stem cells market, by type, 2018 - 2030 (USD Million)
  • Table 10. North America adult stem cells market, by product & services, 2018 - 2030 (USD Million)
  • Table 11. North America adult stem cells market, by indication, 2018 - 2030 (USD Million)
  • Table 12. North America adult stem cells market, by application, 2018 - 2030 (USD Million)
  • Table 13. North America adult stem cells market, by end use, 2018 - 2030 (USD Million)
  • Table 14. U.S. adult stem cells market, by type, 2018 - 2030 (USD Million)
  • Table 15. U.S. adult stem cells market, by product & services, 2018 - 2030 (USD Million)
  • Table 16. U.S. adult stem cells market, by indication, 2018 - 2030 (USD Million)
  • Table 17. U.S. adult stem cells market, by application, 2018 - 2030 (USD Million)
  • Table 18. U.S. adult stem cells market, by end use, 2018 - 2030 (USD Million)
  • Table 19. Canada adult stem cells market, by type, 2018 - 2030 (USD Million)
  • Table 20. Canada adult stem cells market, by product & services, 2018 - 2030 (USD Million)
  • Table 21. Canada adult stem cells market, by indication, 2018 - 2030 (USD Million)
  • Table 22. Canada adult stem cells market, by application, 2018 - 2030 (USD Million)
  • Table 23. Canada adult stem cells market, by end use, 2018 - 2030 (USD Million)
  • Table 24. Mexico adult stem cells market, by type, 2018 - 2030 (USD Million)
  • Table 25. Mexico adult stem cells market, by product & services, 2018 - 2030 (USD Million)
  • Table 26. Mexico adult stem cells market, by indication, 2018 - 2030 (USD Million)
  • Table 27. Mexico adult stem cells market, by application, 2018 - 2030 (USD Million)
  • Table 28. Mexico adult stem cells market, by end use, 2018 - 2030 (USD Million)
  • Table 29. Europe adult stem cells market, by country, 2018 - 2030 (USD Million)
  • Table 30. Europe adult stem cells market, by type, 2018 - 2030 (USD Million)
  • Table 31. Europe adult stem cells market, by product & services, 2018 - 2030 (USD Million)
  • Table 32. Europe adult stem cells market, by indication, 2018 - 2030 (USD Million)
  • Table 33. Europe adult stem cells market, by application, 2018 - 2030 (USD Million)
  • Table 34. Europe adult stem cells market, by end use, 2018 - 2030 (USD Million)
  • Table 35. UK adult stem cells market, by type, 2018 - 2030 (USD Million)
  • Table 36. UK adult stem cells market, by product & services, 2018 - 2030 (USD Million)
  • Table 37. UK adult stem cells market, by indication, 2018 - 2030 (USD Million)
  • Table 38. UK adult stem cells market, by application, 2018 - 2030 (USD Million)
  • Table 39. UK adult stem cells market, by end use, 2018 - 2030 (USD Million)
  • Table 40. Germany adult stem cells market, by type, 2018 - 2030 (USD Million)
  • Table 41. Germany adult stem cells market, by product & services, 2018 - 2030 (USD Million)
  • Table 42. Germany adult stem cells market, by indication 2018 - 2030 (USD Million)
  • Table 43. Germany adult stem cells market, by application, 2018 - 2030 (USD Million)
  • Table 44. Germany adult stem cells market, by end use, 2018 - 2030 (USD Million)
  • Table 45. France adult stem cells market, by type, 2018 - 2030 (USD Million)
  • Table 46. France adult stem cells market, by product & services, 2018 - 2030 (USD Million)
  • Table 47. France adult stem cells market, by indication 2018 - 2030 (USD Million)
  • Table 48. France adult stem cells market, by application, 2018 - 2030 (USD Million)
  • Table 49. France adult stem cells market, by end use, 2018 - 2030 (USD Million)
  • Table 50. Italy adult stem cells market, by type, 2018 - 2030 (USD Million)
  • Table 51. Italy adult stem cells market, by product & services, 2018 - 2030 (USD Million)
  • Table 52. Italy adult stem cells market, by indication, 2018 - 2030 (USD Million)
  • Table 53. Italy adult stem cells market, by application, 2018 - 2030 (USD Million)
  • Table 54. Italy adult stem cells market, by end use, 2018 - 2030 (USD Million)
  • Table 55. Spain adult stem cells market, by type, 2018 - 2030 (USD Million)
  • Table 56. Spain adult stem cells market, by product & services, 2018 - 2030 (USD Million)
  • Table 57. Spain adult stem cells market, by indication, 2018 - 2030 (USD Million)
  • Table 58. Spain adult stem cells market, by application, 2018 - 2030 (USD Million)
  • Table 59. Spain adult stem cells market, by end use, 2018 - 2030 (USD Million)
  • Table 60. Denmark adult stem cells market, by type, 2018 - 2030 (USD Million)
  • Table 61. Denmark adult stem cells market, by product & services, 2018 - 2030 (USD Million)
  • Table 62. Denmark adult stem cells market, by indication 2018 - 2030 (USD Million)
  • Table 63. Denmark adult stem cells market, by application, 2018 - 2030 (USD Million)
  • Table 64. Denmark adult stem cells market, by end use, 2018 - 2030 (USD Million)
  • Table 65. Norway adult stem cells market, by type, 2018 - 2030 (USD Million)
  • Table 66. Norway adult stem cells market, by product & services, 2018 - 2030 (USD Million)
  • Table 67. Norway adult stem cells market, by indication, 2018 - 2030 (USD Million)
  • Table 68. Norway adult stem cells market, by application, 2018 - 2030 (USD Million)
  • Table 69. Norway adult stem cells market, by end use, 2018 - 2030 (USD Million)
  • Table 70. Sweden adult stem cells market, by type, 2018 - 2030 (USD Million)
  • Table 71. Sweden adult stem cells market, by product & services, 2018 - 2030 (USD Million)
  • Table 72. Sweden adult stem cells market, by indication, 2018 - 2030 (USD Million)
  • Table 73. Sweden adult stem cells market, by application, 2018 - 2030 (USD Million)
  • Table 74. Sweden adult stem cells market, by end use, 2018 - 2030 (USD Million)
  • Table 75. Asia Pacific adult stem cells market, by country, 2018 - 2030 (USD Million)
  • Table 76. Asia Pacific adult stem cells market, by type, 2018 - 2030 (USD Million)
  • Table 77. Asia Pacific adult stem cells market, by product & services, 2018 - 2030 (USD Million)
  • Table 78. Asia Pacific adult stem cells market, by indication, 2018 - 2030 (USD Million)
  • Table 79. Asia Pacific adult stem cells market, by application, 2018 - 2030 (USD Million)
  • Table 80. Asia Pacific adult stem cells market, by end use, 2018 - 2030 (USD Million)
  • Table 81. Japan adult stem cells market, by type, 2018 - 2030 (USD Million)
  • Table 82. Japan adult stem cells market, by product & services, 2018 - 2030 (USD Million)
  • Table 83. Japan adult stem cells market, by indication, 2018 - 2030 (USD Million)
  • Table 84. Japan adult stem cells market, by application, 2018 - 2030 (USD Million)
  • Table 85. Japan adult stem cells market, by end use, 2018 - 2030 (USD Million)
  • Table 86. China adult stem cells market, by type, 2018 - 2030 (USD Million)
  • Table 87. China adult stem cells market, by product & services 2018 - 2030 (USD Million)
  • Table 88. China adult stem cells market, by indication 2018 - 2030 (USD Million)
  • Table 89. China adult stem cells market, by application, 2018 - 2030 (USD Million)
  • Table 90. China adult stem cells market, by end use, 2018 - 2030 (USD Million)
  • Table 91. India adult stem cells market, by type, 2018 - 2030 (USD Million)
  • Table 92. India adult stem cells market, by product & services, 2018 - 2030 (USD Million)
  • Table 93. India adult stem cells market, by indication, 2018 - 2030 (USD Million)
  • Table 94. India adult stem cells market, by application, 2018 - 2030 (USD Million)
  • Table 95. India adult stem cells market, by end use, 2018 - 2030 (USD Million)
  • Table 96. Australia adult stem cells market, by type, 2018 - 2030 (USD Million)
  • Table 97. Australia adult stem cells market, by product & services, 2018 - 2030 (USD Million)
  • Table 98. Australia adult stem cells market, by indication, 2018 - 2030 (USD Million)
  • Table 99. Australia adult stem cells market, by application, 2018 - 2030 (USD Million)
  • Table 100. Australia adult stem cells market, by end use, 2018 - 2030 (USD Million)
  • Table 101. South Korea adult stem cells market, by type, 2018 - 2030 (USD Million)
  • Table 102. South Korea adult stem cells market, by product & services, 2018 - 2030 (USD Million)
  • Table 103. South Korea adult stem cells market, by indication, 2018 - 2030 (USD Million)
  • Table 104. South Korea adult stem cells market, by application, 2018 - 2030 (USD Million)
  • Table 105. South Korea adult stem cells market, by end use, 2018 - 2030 (USD Million)
  • Table 106. Thailand adult stem cells market, by type, 2018 - 2030 (USD Million)
  • Table 107. Thailand adult stem cells market, by product & services, 2018 - 2030 (USD Million)
  • Table 108. Thailand adult stem cells market, by indication, 2018 - 2030 (USD Million)
  • Table 109. Thailand adult stem cells market, by application, 2018 - 2030 (USD Million)
  • Table 110. Thailand adult stem cells market, by end use, 2018 - 2030 (USD Million)
  • Table 111. Latin America adult stem cells market, by country, 2018 - 2030 (USD Million)
  • Table 112. Latin America adult stem cells market, by type, 2018 - 2030 (USD Million)
  • Table 113. Latin America adult stem cells market, by product & services, 2018 - 2030 (USD Million)
  • Table 114. Latin America adult stem cells market, by indication, 2018 - 2030 (USD Million)
  • Table 115. Latin America adult stem cells market, by application, 2018 - 2030 (USD Million)
  • Table 116. Latin America adult stem cells market, by end use, 2018 - 2030 (USD Million)
  • Table 117. Brazil adult stem cells market, by type, 2018 - 2030 (USD Million)
  • Table 118. Brazil adult stem cells market, by product & services, 2018 - 2030 (USD Million)
  • Table 119. Brazil adult stem cells market, by indication, 2018 - 2030 (USD Million)
  • Table 120. Brazil adult stem cells market, by application, 2018 - 2030 (USD Million)
  • Table 121. Brazil adult stem cells market, by end use, 2018 - 2030 (USD Million)
  • Table 122. Argentina adult stem cells market, by type, 2018 - 2030 (USD Million)
  • Table 123. Argentina adult stem cells market, by product & services, 2018 - 2030 (USD Million)
  • Table 124. Argentina adult stem cells market, by indication, 2018 - 2030 (USD Million)
  • Table 125. Argentina adult stem cells market, by application, 2018 - 2030 (USD Million)
  • Table 126. Argentina adult stem cells market, by end use, 2018 - 2030 (USD Million)
  • Table 127. Middle East & Africa adult stem cells market, by country, 2018 - 2030 (USD Million)
  • Table 128. Middle East & Africa adult stem cells market, by type, 2018 - 2030 (USD Million)
  • Table 129. Middle East & Africa adult stem cells market, by product & services, 2018 - 2030 (USD Million)
  • Table 130. Middle East & Africa adult stem cells market, by indication, 2018 - 2030 (USD Million)
  • Table 131. Middle East & Africa adult stem cells market, by application, 2018 - 2030 (USD Million)
  • Table 132. Middle East & Africa adult stem cells market, by end use, 2018 - 2030 (USD Million)
  • Table 133. South Africa adult stem cells market, by type, 2018 - 2030 (USD Million)
  • Table 134. South Africa adult stem cells market, by product & services, 2018 - 2030 (USD Million)
  • Table 135. South Africa adult stem cells market, by indication, 2018 - 2030 (USD Million)
  • Table 136. South Africa adult stem cells market, by application, 2018 - 2030 (USD Million)
  • Table 137. South Africa adult stem cells market, by end use, 2018 - 2030 (USD Million)
  • Table 138. Saudi Arabia adult stem cells market, by type, 2018 - 2030 (USD Million)
  • Table 139. Saudi Arabia adult stem cells market, by product & services, 2018 - 2030 (USD Million)
  • Table 140. Saudi Arabia adult stem cells market, by indication, 2018 - 2030 (USD Million)
  • Table 141. Saudi Arabia adult stem cells market, by application, 2018 - 2030 (USD Million)
  • Table 142. Saudi Arabia adult stem cells market, by end use, 2018 - 2030 (USD Million)
  • Table 143. UAE adult stem cells market, by type, 2018 - 2030 (USD Million)
  • Table 144. UAE adult stem cells market, by product & services, 2018 - 2030 (USD Million)
  • Table 145. UAE adult stem cells market, by indication, 2018 - 2030 (USD Million)
  • Table 146. UAE adult stem cells market, by application, 2018 - 2030 (USD Million)
  • Table 147. UAE adult stem cells market, by end use, 2018 - 2030 (USD Million)
  • Table 148. Kuwait adult stem cells market, by type, 2018 - 2030 (USD Million)
  • Table 149. Kuwait adult stem cells market, by product & services, 2018 - 2030 (USD Million)
  • Table 150. Kuwait adult stem cells market, by indication, 2018 - 2030 (USD Million)
  • Table 151. Kuwait adult stem cells market, by application, 2018 - 2030 (USD Million)
  • Table 152. Kuwait adult stem cells market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig 1. Adult stem cells market segmentation
  • Fig 2. Data analysis models
  • Fig 3. Market formulation and validation
  • Fig 4. Data validating & publishing
  • Fig 5. Market research process
  • Fig 6. Information procurement
  • Fig 7. Primary research
  • Fig 8. Value-chain-based sizing & forecasting
  • Fig 9. QFD modelling for market share assessment
  • Fig 10. Market formulation & validation
  • Fig 11. Commodity flow analysis
  • Fig 12. Market outlook
  • Fig 13. Segment snapshot-1
  • Fig 14. Segment snapshot-2
  • Fig 15. Competitive landscape snapshot
  • Fig 16. Market trends & outlook
  • Fig 17. Porter's five force analysis
  • Fig 18. PESTEL analysis
  • Fig 19. Adult stem cells market, type outlook key takeaways (USD Million)
  • Fig 20. Adult stem cells market: type movement analysis (USD Million), 2023 & 2030
  • Fig 21. Autologous adult stem cells market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 22. Allogeneic adult stem cells market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 23. Adult stem cells market, product & services outlook key takeaways (USD Million)
  • Fig 24. Adult stem cells market: product & services movement analysis (USD Million), 2023 & 2030
  • Fig 25. Product market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 26. Kits, media, & reagents market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 27. Cells & cell lines market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 28. Hematopoietic market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 29. Mesenchymal market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 30. Neural market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 31. Epithelial/Skin market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 32. Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 33. Services market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 34. Adult stem cells market, indication outlook key takeaways (USD Million)
  • Fig 35. Adult stem cells market: indication movement analysis (USD Million), 2023 & 2030
  • Fig 36. Bone and cartilage repair market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 37. Cardiovascular diseases market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 38. Inflammatory and immunological diseases market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 39. Liver diseases market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 40. Cancer market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 41. GvHD market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 42. Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 43. Adult stem cells market, application outlook key takeaways (USD Million)
  • Fig 44. Adult stem cells market: application movement analysis (USD Million), 2023 & 2030
  • Fig 45. Therapeutics market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 46. Disease modeling market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 47. Drug development & discovery market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 48. Toxicology studies market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 49. Biobanking market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 50. Tissue engineering market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 51. Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 52. Adult stem cells market, end use outlook key takeaways (USD Million)
  • Fig 53. Adult stem cells market: end use movement analysis (USD Million), 2023 & 2030
  • Fig 54. Hospitals & clinics market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 55. Research institutes market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 56. Biopharmaceutical companies market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 57. Adult stem cells market: regional key takeaways (USD Million)
  • Fig 58. Adult stem cells market: regional outlook, 2023 & 2030, USD billion
  • Fig 59. North America adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 60. U.S. adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 61. Canada adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 62. Mexico adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 63. Europe adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 64. UK adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 65. Germany adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 66. France adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 67. Spain adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 68. Italy adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 69. Norway adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 70. Denmark adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 71. Sweden adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 72. Asia Pacific adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 73. China adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 74. Japan adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 75. India adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 76. South Korea adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 77. Australia adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 78. Thailand adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 79. Latin America adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 80. Brazil adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 81. Argentina adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 82. Middle East and Africa adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 83. South Africa adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 84. Saudi Arabia adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 85. UAE adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 86. Kuwait adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 87. List of key emerging company's/technology disruptors/innovators